Showing results (211-220 of 375) with videos related to

Sort By:
Pageof 38
Pharmaceutical Biology|September 9, 2010
Antipyretic and antinociceptive effects of Nauclea latifolia root decoction and possible mechanisms of actionGermain Sotoing Taïwe, Elisabeth Ngo Bum, Emmanuel Talla, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 26, 2025
Asymmetric Dimethylarginine: A Never-Aging StoryNatalia Jarzebska, Stefan R Bornstein, Sergey Tselmin, et al.
Cardiovascular Research|June 4, 2005
Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic ratsLars S Maier, Christian Wahl-Schott, Wiebke Horn, et al.
Neuromuscular Disorders : NMD|February 21, 2019
Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) miceRalf Bauer, Helene Enns, Andreas Jungmann, et al.
Gene Therapy|December 18, 2024
AAV library screening identifies novel vector for efficient transduction of human aortaLena C Schröder, Leonard Hüttermann, Anca Kliesow Remes, et al.
Molecular Therapy. Methods & Clinical Development|November 14, 2019
AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic AllograftsAnca Remes, Maximilian Franz, Franziska Mohr, et al.
Neurological Research and Practice|December 16, 2020
Prevention of thromboembolism in spinal cord injury -S1 guidelineNorbert Weidner, Oliver J Müller, Viola Hach-Wunderle, et al.
Cardiovascular Research|August 2, 2014
Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinaseStanislas Werfel, Andreas Jungmann, Lorenz Lehmann, et al.
Thrombosis and Haemostasis|March 6, 2015
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC RegistryJan Beyer-Westendorf, Franziska Ebertz, Kait Förster, et al.
Atherosclerosis. Supplements|November 4, 2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathyRoman N Rodionov, Annett Heinrich, Silke Brilloff, et al.
Pageof 38